AAAAAA

   
Results: 1-25 |
Results: 25
ALLOGENEIC STEM-CELL TRANSPLANTATION FOLLOWED BY PREEMPTIVE DONOR LYMPHOCYTE INFUSIONS FOR REFRACTORY LEUKEMIA AND SARCOMA
Authors: JULIUSSON G MALM C CARLSSON MS KARLSSON K ENGQUIST L STARKHAMMAR H ERNERUDH J SEGERMOLLEN A
Citation: G. Juliusson et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOLLOWED BY PREEMPTIVE DONOR LYMPHOCYTE INFUSIONS FOR REFRACTORY LEUKEMIA AND SARCOMA, Bone marrow transplantation, 21, 1998, pp. 231-231
POOR SURVIVAL IN T(8-21)(Q22-Q22)-ASSOCIATED ACUTE MYELOID-LEUKEMIA WITH LEUKOCYTOSIS
Authors: BILLSTROM R JOHANSSON B FIORETOS T GARWICZ S MALM C ZETTERVALL O MITELMAN F
Citation: R. Billstrom et al., POOR SURVIVAL IN T(8-21)(Q22-Q22)-ASSOCIATED ACUTE MYELOID-LEUKEMIA WITH LEUKOCYTOSIS, European journal of haematology, 59(1), 1997, pp. 47-52
DELETION OF CHROMOSOME ARM 3P IN HEMATOLOGIC MALIGNANCIES
Authors: JOHANSSON B BILLSTROM R KRISTOFFERSSON U AKERMAN M GARWICZ S AHLGREN T MALM C MITELMAN F
Citation: B. Johansson et al., DELETION OF CHROMOSOME ARM 3P IN HEMATOLOGIC MALIGNANCIES, Leukemia, 11(8), 1997, pp. 1207-1213
THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P EKLUND SG NORDLANDER S LARFARS G LEIJD B LINDER O LOOGNA E GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J SVENSSON E DAHLIN L BOBERG J MARJANOVICS B JONSSON KA MALM C HJORTH M LINDGREN A FAGRELL B KALLNER M WADMAN B SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G LINDER O BJORKHOLM M CARNESKOG J STENKE L KARLE H LANNGNIELSEN J LOFVENBERG E MALM C PAUL C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Blood, 90(10), 1997, pp. 1744-1744
EFFECTS OF UBIQUINONE-10 SUPPLEMENTATION AND HIGH-INTENSITY TRAINING ON PHYSICAL PERFORMANCE IN HUMANS
Authors: MALM C SVENSSON M EKBLOM B SJODIN B
Citation: C. Malm et al., EFFECTS OF UBIQUINONE-10 SUPPLEMENTATION AND HIGH-INTENSITY TRAINING ON PHYSICAL PERFORMANCE IN HUMANS, Acta Physiologica Scandinavica, 161(3), 1997, pp. 379-384
NRAS MUTATIONS ARE RARE IN ACUTE MYELOID LEUKEMIAS WITH T(8-21) OR INV(16)
Authors: PANAGOPOULOS I AMAN P JOHANSSON B MALM C LENHOFF S BILLSTROM R MITELMAN F
Citation: I. Panagopoulos et al., NRAS MUTATIONS ARE RARE IN ACUTE MYELOID LEUKEMIAS WITH T(8-21) OR INV(16), European journal of haematology, 56(1-2), 1996, pp. 68-71
THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S WIMAN B CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORTH M FAGRELL B KALLNER M GRANQVIST S EGBERG N SCHULMAN S WADMAN B SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G BJOREMAN M BJORKHOLM M CARNESKOG J GAHRTON G HAST R KARL H LANNGNIELSEN J LOFVENBERG E MALM C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Bone marrow transplantation, 17, 1996, pp. 63-64
'MARRIAGE'
Authors: MALM C
Citation: C. Malm, 'MARRIAGE', The North American review, 281(5), 1996, pp. 25-25
SUPPLEMENTATION WITH UBIQUINONE-10 CAUSES CELLULAR-DAMAGE DURING INTENSE EXERCISE
Authors: MALM C SVENSSON M SJOBERG B EKBLOM B SJODIN B
Citation: C. Malm et al., SUPPLEMENTATION WITH UBIQUINONE-10 CAUSES CELLULAR-DAMAGE DURING INTENSE EXERCISE, Acta Physiologica Scandinavica, 157(4), 1996, pp. 511-512
PRODUCTION OF TRANSFORMING GROWTH-FACTOR-ALPHA BY HUMAN LEUKEMIA-CELLS (HL-60 AND U-937) DURING MONOCYTIC DIFFERENTIATION
Authors: WALZ TM MALM C NISHIKAWA BK WILLANDER K WINGREN S WASTESON A
Citation: Tm. Walz et al., PRODUCTION OF TRANSFORMING GROWTH-FACTOR-ALPHA BY HUMAN LEUKEMIA-CELLS (HL-60 AND U-937) DURING MONOCYTIC DIFFERENTIATION, Leukemia, 9(4), 1995, pp. 671-676
SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA
Authors: JULIUSSON G HELDAL D HIPPE E HEDENUS M MALM C WALLMAN K STOLT CM EVENSEN SA ALBERTIONI F TJONNFJORD G LENKEI R LILIEMARK J
Citation: G. Juliusson et al., SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 13(4), 1995, pp. 989-995
A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S RHEDIN AS LINDMARKER P CARLSSON A LARFARS G NICOL P LOOGNA E SVENSSON E LJUNGBERG B WALTER H VIERING S NORDLANDER S LEIJD B JONSSON KA HJORTH M LINDER O BOBERG J GUSTAFSSON C GRONDAHL A TORNEBOHM E JOHANSSON M LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R WILHELMSSON S OHLSSON A MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J EKLUND SG DAHLIN L MARJANOVICS B MALM C LINDGREN A FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N WADMAN B SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) IN HUMAN BONE-MARROW - DEMONSTRATION OF TGF-ALPHA IN ERYTHROBLASTS AND EOSINOPHILIC PRECURSOR CELLS AND OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN BLASTLIKE CELLS OF MYELOMONOCYTIC ORIGIN
Authors: WALZ TM MALM C NISHIKAWA BK WASTESON A
Citation: Tm. Walz et al., TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) IN HUMAN BONE-MARROW - DEMONSTRATION OF TGF-ALPHA IN ERYTHROBLASTS AND EOSINOPHILIC PRECURSOR CELLS AND OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN BLASTLIKE CELLS OF MYELOMONOCYTIC ORIGIN, Blood, 85(9), 1995, pp. 2385-2392
QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN
Authors: SCHULMAN S CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORT M FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N
Citation: S. Schulman et al., QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 143-152
TRANSFORMING GROWTH-FACTOR-ALPHA EXPRESSION IN NORMAL HUMAN BLOOD EOSINOPHILS - DIFFERENTIAL REGULATION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3
Authors: WALZ TM NISHIKAWA BK MALM C BRIHEIM K WASTESON A
Citation: Tm. Walz et al., TRANSFORMING GROWTH-FACTOR-ALPHA EXPRESSION IN NORMAL HUMAN BLOOD EOSINOPHILS - DIFFERENTIAL REGULATION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3, Leukemia, 8(4), 1994, pp. 612-619
TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) IN HUMAN BONE-MARROW - DEMONSTRATION OF TGF-ALPHA IN ERYTHROBLASTS AND EOSINOPHILIC PRECURSOR CELLS AND OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN BLAST-LIKE CELLS OF MYELOMONOCYTIC ORIGIN
Authors: WALZ TM MALM C NISHIKAWA BK WASTESON A
Citation: Tm. Walz et al., TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) IN HUMAN BONE-MARROW - DEMONSTRATION OF TGF-ALPHA IN ERYTHROBLASTS AND EOSINOPHILIC PRECURSOR CELLS AND OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN BLAST-LIKE CELLS OF MYELOMONOCYTIC ORIGIN, Experimental hematology, 22(8), 1994, pp. 745-745
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML)
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G STENKE L TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML), Bone marrow transplantation, 14, 1994, pp. 55-56
INFECTION OF DONOR LYMPHOCYTES WITH HUMAN T-LYMPHOTROPHIC VIRUS TYPE-1 (HTLV-I) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HTLV-IPOSITIVE ADULT T-CELL LEUKEMIA
Authors: LJUNGMAN P LAWLER M ASJO B BOGDANOVIC G KARLSSON K MALM C MCCANN SR RINGDEN O GAHRTON G
Citation: P. Ljungman et al., INFECTION OF DONOR LYMPHOCYTES WITH HUMAN T-LYMPHOTROPHIC VIRUS TYPE-1 (HTLV-I) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HTLV-IPOSITIVE ADULT T-CELL LEUKEMIA, British Journal of Haematology, 88(2), 1994, pp. 403-405
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G HAST R TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA, Stem cells, 11, 1993, pp. 73-76
CLINICAL IMPACT OF BREAKPOINT POSITION WITHIN M-BCR IN CHRONIC MYELOID-LEUKEMIA
Authors: FIORETOS T NILSSON PG AMAN P HEIM S KRISTOFFERSSON U MALM C SIMONSSON B TURESSON I MITELMAN F
Citation: T. Fioretos et al., CLINICAL IMPACT OF BREAKPOINT POSITION WITHIN M-BCR IN CHRONIC MYELOID-LEUKEMIA, Leukemia, 7(8), 1993, pp. 1225-1231
PRODUCTION OF TRANSFORMING GROWTH-FACTOR-ALPHA BY NORMAL HUMAN BLOOD EOSINOPHILS
Authors: WALZ TM NISHIKAWA BK MALM C WASTESON A
Citation: Tm. Walz et al., PRODUCTION OF TRANSFORMING GROWTH-FACTOR-ALPHA BY NORMAL HUMAN BLOOD EOSINOPHILS, Leukemia, 7(10), 1993, pp. 1531-1537
EXPRESSION OF TRANSFORMING GROWTH-FACTOR-ALPHA IN HUMAN MONOCYTIC CELL-DIFFERENTIATION
Authors: WALZ TM NISHIKAWA BK MALM C WASTESON A
Citation: Tm. Walz et al., EXPRESSION OF TRANSFORMING GROWTH-FACTOR-ALPHA IN HUMAN MONOCYTIC CELL-DIFFERENTIATION, Experimental hematology, 21(8), 1993, pp. 1037-1037
HEART-FAILURE AFTER PARVOVIRUS-B19 INFECTION
Authors: MALM C FRIDELL E JANSSON K
Citation: C. Malm et al., HEART-FAILURE AFTER PARVOVIRUS-B19 INFECTION, Lancet, 341(8857), 1993, pp. 1408-1409
Risultati: 1-25 |